Acorah Software Products - Accounts Production15.0.600falsetruefalsetrueNo description of principal activity26 June 202330 June 202430 June 202414960522Mr Andrew Grahamiso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure149605222023-06-25149605222024-06-30149605222023-06-262024-06-3014960522frs-core:CurrentFinancialInstruments2024-06-3014960522frs-bus:PrivateLimitedCompanyLtd2023-06-262024-06-3014960522frs-bus:FilletedAccounts2023-06-262024-06-3014960522frs-bus:Micro-entities2023-06-262024-06-3014960522frs-bus:AuditExempt-NoAccountantsReport2023-06-262024-06-3014960522frs-bus:Director12023-06-262024-06-30
JAG Clinical Limited
Unaudited Financial Statements
For The Year Ended 30 June 2024
JAG Clinical Limited
Balance Sheet
As At 30 June 2024
Balance Sheet
Registered number: 14960522
2024
£
Current assets
31,215
Creditors: Amounts Falling Due Within One Year
(14,071)
NET CURRENT ASSETS
17,144
TOTAL ASSETS LESS CURRENT LIABILITIES
17,144
Accruals and deferred income
(480)
NET ASSETS
16,664
CAPITAL AND RESERVES
16,664
Notes
1.General Information
JAG Clinical Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14960522. The registered office is 17 Springbank, Peterlee, Co. Durham, SR8 1FA.
2.Average Number of Employees
Average number of employees, including directors, during the year was: 2
2
Page 0
Page 1
JAG Clinical Limited
Balance Sheet (continued)
As At 30 June 2024
For the year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.